Bioanalytical Systems Inc., 2701 Kent Ave., West Lafayette, 47906, provides contract-research services to the pharmaceutical industry. In the fiscal first quarter, which ended Dec. 31, 2016, Bioanalytical earned $17,000, or zero cents per share, on revenue of $6.2 million. In the same period a year earlier, the company lost $506,000, or 6 cents per share, on revenue of $4.9 million. Bioanalytical shares trade on NASDAQ under the ticker BASI. Information for Proxy Corner was taken from Yahoo Finance and the company’s proxy statement dated Feb. 3, 2017. View full Proxy Corner feature.